Last edition
News about Global Pharma
Ipsen and Exicure have signed an exclusive collaboration agreement to research, develop, and commercialize novel spherical nucleic acids (SNAs) as potential investigational treatments for Huntington's disease and Angelman syndrome
Global Pharma | 03/08/2021 | By Darshana | 176
AbbVie, Calico Life extend partnership to discover & develop new therapies
AbbVie and Calico Life Sciences announced an extension of their leading-edge collaboration to discover, develop and bring to market new therapies for patients with age-related diseases, including neurodegeneration and cancer. This is the second extension of the collaboration originally established in 2014
Global Pharma | 29/07/2021 | By Darshana | 219
AstraZeneca completes acquisition of Alexion Pharmaceuticals
AstraZeneca completed the acquisition of Alexion Pharmaceuticals, (Alexion). The closing of the acquisition marks the company's entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca
Global Pharma | 23/07/2021 | By Darshana | 178
US FDA approves Merck's Vaxneuvance for prevention of invasive pneumococcal disease
Vaxneuvance is contraindicated for individuals with a history of severe allergic reaction (e.g., anaphylaxis) to any component of Vaxneuvance or to diphtheria toxoid; see additional Select Safety Information below
Global Pharma | 19/07/2021 | By Darshana | 252
Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), and Alyatec, a contract research organisation based in Strasbourg University Hospital (France), announced that they have entered into a collaboration to advance precision medicine in AIT
Global Pharma | 12/07/2021 | By Darshana | 131
Managed by the Broad Institute of MIT and Harvard, the browser gives access to results from analyses of whole exome sequencing data from 300,000 UK Biobank research participants. These genetic data have been paired with detailed health information to create this browsable resource
Global Pharma | 10/07/2021 | By Darshana | 117
Sinomed, a leading international medical device company, announced that they have teamed up with the National University of Ireland Galway (NUI Galway) to conduct a clinical trial for a new assessment method for stenting
Global Pharma | 06/07/2021 | By Darshana | 151
Moderna begins manufacturing of Covid-19 vaccine at Recipharm site in France
Moderna Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines; and Recipharm, a leading contract development and manufacturing organization, confirmed that following the European Medicines Agency's (EMA) Committee for Human Medicines (CHMP) approval of the Recipharm Monts site on June 11, 2021, drug product manufacture
Global Pharma | 03/07/2021 | By Darshana | 188
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in international markets, announced a new agreement to commercialize the Moderna Covid-19 vaccine across Central Eastern Europe and Israel
Global Pharma | 08/06/2021 | By Darshana | 146
Bayer enters agreement to buy Noria Therapeutics and PSMA Therapeutics
Bayer announced that it has entered into an agreement to acquire Noria Therapeutics (Noria) and PSMA Therapeutics. Through this acquisition, Bayer will obtain exclusive rights to a differentiated alpha radionuclide investigational compound based on actinium-225 and a small molecule directed towards prostate-specific membrane antigen (PSMA)
Global Pharma | 06/06/2021 | By Darshana | 197
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy